Quadrature Capital Ltd Buys Shares of 35,837 The Joint Corp. (NASDAQ:JYNT)

Quadrature Capital Ltd bought a new position in shares of The Joint Corp. (NASDAQ:JYNT – Get Rating) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 35,837 shares of the company’s stock, valued at approximately $563,000. Quadrature Capital Ltd owned 0.25% of Joint at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Swiss National Bank grew its holdings in Joint by 8.6% during the first quarter. Swiss National Bank now owns 34,100 shares of the company’s stock valued at $1,207,000 after purchasing an additional 2,700 shares during the period. JPMorgan Chase & Co. raised its stake in Joint by 8.2% during the 1st quarter. JPMorgan Chase & Co. now owns 16,212 shares of the company’s stock worth $574,000 after buying an additional 1,228 shares during the period. Citigroup Inc. lifted its holdings in Joint by 26.6% during the first quarter. Citigroup Inc. now owns 13,870 shares of the company’s stock worth $491,000 after acquiring an additional 2,915 shares in the last quarter. Acadian Asset Management LLC grew its stake in Joint by 22.4% in the first quarter. Acadian Asset Management LLC now owns 8,946 shares of the company’s stock valued at $315,000 after acquiring an additional 1,640 shares during the period. Finally, MetLife Investment Management LLC increased its holdings in shares of Joint by 58.0% in the first quarter. MetLife Investment Management LLC now owns 8,041 shares of the company’s stock worth $285,000 after acquiring an additional 2,953 shares in the last quarter. 88.13% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, B. Riley boosted their price objective on Joint from $23.00 to $26.00 in a research report on Friday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $32.33.

Joint Stock Up 1.5 %

JYNT stock opened at $16.50 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.87 and a quick ratio of 0.87. The stock has a market capitalization of $239.75 million, a P/E ratio of 206.25 and a beta of 1.35. The Joint Corp. has a fifty-two week low of $12.85 and a fifty-two week high of $40.22. The business has a 50-day moving average of $16.59 and a 200-day moving average of $16.22.

Insider Buying and Selling at Joint

In other Joint news, major shareholder Bandera Partners Llc purchased 40,339 shares of the firm’s stock in a transaction dated Tuesday, January 3rd. The stock was bought at an average cost of $13.45 per share, with a total value of $542,559.55. Following the purchase, the insider now directly owns 2,570,087 shares of the company’s stock, valued at $34,567,670.15. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 3.50% of the company’s stock.

Joint Company Profile

(Get Rating)

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit.